Myocardial dysfunction and depressed fatty acid metabolism in patients with cyanotic congenital heart disease

Journal of Nuclear Cardiology

Volumn 3, Issue 1, 1996, Pages 30-36

  Kondo, Chisato ^a   Nakazawa, Makoto ^a   Kusakabe, Kiyoko ^a   Momma, Kazuo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Congenital; Heart defects; Myocardial metabolism

Indexed keywords

DECANOIC ACID DERIVATIVE; IODINE 123; THALLIUM;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYANOTIC HEART DISEASE; FATTY ACID METABOLISM; FEMALE; HEART CINEVENTRICULOGRAPHY; HEART CONTRACTION; HEART MUSCLE METABOLISM; HEART PERFUSION; HEART SCINTISCANNING; HEART SINGLE VENTRICLE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

EID: 0030066072     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(96)90021-5     Document Type: Article

References (22)

1. Becker AE, Caruso G. Congenital heart disease: a morphologist's view on myocardial dysfunction. In: Becker AE, Losekoot TG, Marcelletti C, Anderson RH, eds. Paediatric cardiology. Vol. 3. Edinburg: Churchill Livingstone, 1981:307-23.
2. Jones M, Ferrans VJ. Myocardial ultrastructure in congenital heart disease. In: Roberts WC, ed. Adult congenital heart disease. Philadelphia: FA Davis, 1987:49-76.
3. Goodman MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted α- and β-methyl-branched fatty acids. J Med Chem 1984;27:390-7.
4. Livni E, Elmaleh DR, Barlai-Kovach MM, Goodman MM, Knapp FF Jr, Strauss HW. Radioiodinated beta-methyl phenyl fatty acids as potential tracers for myocardial imaging and metabolism. Eur Heart J 1985;6(suppl B):85-9.
5. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-67.
6. Saito T, Yasuda T, Gold HK, et al. Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury. Nucl Med Commun 1991;12:663-75.
7. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-91.
8. Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994;8:47-54.
9. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-22.
10. Kondo C, Hiroe M, Nakanishi T, Takao A. Detection of coronary artery stenosis in children with Kawasaki disease. Circulation 1989;80:615-24.
11. Kondo C, Nakanishi T, Sonobe T, Tatara K, Momma K, Kusakabe K. Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease. Am J Cardiol 1993;71: 681-5.
12. Kropp J, Ambrose KR, Knapp FF Jr, Nissen HP, Biersack HJ. Incorporation of radioiodinated IPPA and BMIPP fatty acid analogues into complex lipids from isolated rat hearts. Nucl Med Biol 1992;19:283-8.
13. Yamamichi Y, Kusuoka H, Morishita K. Metabolism of I-123-labeled-15-(p-iodophenyl)-3-(R,S)-methyl-pentadecanoic acid (BMIPP) in perfused rat hearts. J Nucl Med 1995;36:1043-50.
14. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12:S39-44.
15. Ambrose KR, Owen BA, Goodman MM, Knapp FF Jr. Evaluation of the metabolism in rat hearts of two new radioiodinated 3-methyl-branched fatty acid myocardial imaging agents. Eur J Nucl Med 1987;12:486-91.
16. Tamaki N, Kawamoto M, Yonekura Y, et al. Assessment of fatty acid metabolism using I-123 branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7(suppl II):SII41-7.
17. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophie cardiomyopathy. Eur J Nucl Med 1992;19:775-82.
18. Kurata C, Tawarahara K, Taniguchi T, et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992;33:6-13.
19. 131I)-iodophenyl-β-methylpentadecanoic acid in normotensive and hypertensive rats. J Nucl Med 1986;27:1178-83.
20. 125I](p-Iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP), and correlation to ATP concentration, II: studies in salt-induced hypertensive rats. Nucl Med Biol 1993;20:163-6.
21. Opie LH. The Heart. Physiology and metabolism. 2nd ed. New York: Raven Press, 1991:208.
22. Neufeld HN, Schneeweiss A. Coronary artery disease in infants and children. Philadelphia: Lea & Febiger, 1983:79.